Organochalcogens inhibit mitochondrial complexes I and II in rat brain: possible implications for neurotoxicity

Robson Luiz Puntel1, Daniel Henrique Roos, Rodrigo Lopes Seeger

  • 1Universidade Federal do Pampa, Campus Uruguaiana BR-472 Km 7, Uruguaiana, RS 97500-970, Brazil. robson_puntel@yahoo.com.br

Neurotoxicity Research
|December 11, 2012
PubMed

Insights

Organochalcogens, like organoselenium and organotellurium, inhibit rat brain mitochondrial complexes I and II. This neurotoxicity is linked to thiol oxidation, impacting neurological disorder research.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Toxicology

Background:

  • Organochalcogens (organoselenium, organotellurium) exhibit neurotoxicity in rodents.
  • Mitochondrial dysfunction is a key factor in neurological disorders.

Purpose of the Study:

  • To investigate if rat brain mitochondrial complexes are molecular targets of organochalcogens.
  • To elucidate the mechanism of organochalcogen-induced neurotoxicity.

Main Methods:

  • Assessing the impact of organochalcogens on rat brain mitochondrial complexes I, II, and IV.
  • Investigating the role of NADH and reduced glutathione (GSH) in modulating these effects.

Main Results:

  • Organochalcogens significantly inhibited mitochondrial complex I activity, an effect reversed by NADH and blunted by GSH.
  • Complex II inhibition was observed with Ebs and (PhTe)₂, also blunted by GSH.
  • Mitochondrial complex IV activity remained unaffected by organochalcogens.
  • Organochalcogens were more potent inhibitors of complex I than complex II.

Conclusions:

  • Organochalcogens target mitochondrial complexes I and II, suggesting a mechanism involving thiol oxidation.
  • These findings provide insights into the neurotoxic mechanisms of organochalcogens and their potential role in neurological disorders.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...